Cyclacel Pharma (CYCC) Misses Q4 EPS by 12c
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.60), $0.12 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q4 EPS of ($0.60), $0.12 worse than the analyst estimate of ($0.48).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.